Colchicine (Colcirex)
Colchicine
Ascend Laboratories (Pty) Ltd
Registration
- Applicant
- Ascend Laboratories (Pty) Ltd
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Colcirex 0,5 MG EACH TABLET CONTAINS: COLCHICINE 0,5 mg | 0,5 mg | 57029757/3.3/0297 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S3: Colchicine
- except when intended for the emergency treatment of acute gout, subject to a maximum total treatment course of 6 milligrams. (S2)
Consolidated Schedules 06 July 2026, lines 3374 to 3375
S2: Colchicine
- when intended for the emergency treatment of acute gout, subject to a maximum total treatment course of 6 milligrams. (S3)
Consolidated Schedules 06 July 2026, lines 1780 to 1781
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
N-[(7S)-1,2,3,10-Tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide
Drag to rotate. Structure from PubChem CID 6167.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.